The U.S. Supreme Court rules that reverse patent settlements may violate antitrust law (Actavis)

FTC v. Actavis, Inc.: Supreme Court Rules That Reverse Patent Settlements May Violate Antitrust Laws* On June 17, 2013, in FTC v. Actavis, Inc., the Supreme Court ruled that "reverse patent settlements" may violate the Sherman Act even though the anticompetitive effects of the settlement fall within the potential scope of the patent. The Court's 5-to-3 ruling resolved a circuit split between the Third Circuit, which had held reverse patent settlements presumptively unlawful under the "quick look" approach, and the Eleventh Circuit, which had held reverse patent settlements immune from antitrust scrutiny so long as the anticompetitive effects of the settlement was within the potential scope of the patent. Although the Supreme Court rejected the Eleventh Circuit's approach, the Court

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Womble Bond Dickinson (Washington D.C.)

Quotation

Jason C. Hicks, The U.S. Supreme Court rules that reverse patent settlements may violate antitrust law (Actavis), 17 June 2013, e-Competitions Bulletin June 2013, Art. N° 54927

Visites 425

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues